WallStSmart

ASP Isotopes Inc. Common Stock (ASPI)vsHuntsman Corporation (HUN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Huntsman Corporation generates 21042% more annual revenue ($5.69B vs $26.93M). ASPI leads profitability with a 0.0% profit margin vs -5.8%. HUN earns a higher WallStSmart Score of 49/100 (D+).

ASPI

Avoid

31

out of 100

Grade: F

Growth: 6.3Profit: 2.5Value: 6.7Quality: 6.0
Piotroski: 4/9Altman Z: -0.12

HUN

Hold

49

out of 100

Grade: D+

Growth: 4.7Profit: 2.0Value: 3.7Quality: 4.5
Piotroski: 1/9Altman Z: 1.67
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ASPIUndervalued (+80.8%)

Margin of Safety

+80.8%

Fair Value

$29.49

Current Price

$6.71

$22.78 discount

UndervaluedFair: $29.49Overvalued
HUNSignificantly Overvalued (-22.6%)

Margin of Safety

-22.6%

Fair Value

$11.47

Current Price

$14.21

$2.74 premium

UndervaluedFair: $11.47Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ASPI2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
279.3%10/10

Revenue surging 279.3% year-over-year

Price/BookValuation
2.9x8/10

Reasonable price relative to book value

HUN2 strengths · Avg: 9.0/10
Price/BookValuation
0.9x10/10

Reasonable price relative to book value

EPS GrowthGrowth
20.6%8/10

Earnings expanding 20.6% YoY

Areas to Watch

ASPI4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$950.57M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Return on EquityProfitability
-60.0%2/10

ROE of -60.0% — below average capital efficiency

HUN4 concerns · Avg: 3.8/10
PEG RatioValuation
2.224/10

Expensive relative to growth rate

Revenue GrowthGrowth
0.7%4/10

0.7% revenue growth

Altman Z-ScoreHealth
1.674/10

Distress zone — elevated risk

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : ASPI

The strongest argument for ASPI centers on Revenue Growth, Price/Book. Revenue growth of 279.3% demonstrates continued momentum.

Bull Case : HUN

The strongest argument for HUN centers on Price/Book, EPS Growth.

Bear Case : ASPI

The primary concerns for ASPI are EPS Growth, Market Cap, Profit Margin.

Bear Case : HUN

The primary concerns for HUN are PEG Ratio, Revenue Growth, Altman Z-Score.

Key Dynamics to Monitor

ASPI profiles as a hypergrowth stock while HUN is a turnaround play — different risk/reward profiles.

ASPI carries more volatility with a beta of 3.27 — expect wider price swings.

ASPI is growing revenue faster at 279.3% — sustainability is the question.

ASPI generates stronger free cash flow (-24M), providing more financial flexibility.

Bottom Line

HUN scores higher overall (49/100 vs 31/100). ASPI offers better value entry with a 80.8% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

ASP Isotopes Inc. Common Stock

BASIC MATERIALS · CHEMICALS · USA

Aspire Real Estate Investors, Inc. focuses on investing, developing, remodeling and managing a portfolio of multi-family properties in metropolitan areas of the United States. The company is headquartered in Irvine, California.

Huntsman Corporation

BASIC MATERIALS · CHEMICALS · USA

Huntsman Corporation manufactures and sells differentiated organic chemicals globally. The company is headquartered in The Woodlands, Texas.

Visit Website →

Want to dig deeper into these stocks?